Skip to content
Recall Observatory FDA recall evidence

Drug product

Minivelle (estradiol transdermal system) Delivers 0.075 mg/day, 8 patches/box, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. by: Noven Therapeutics, LLC Miami, Florida 33186, NDC 68968-6675-8

D-0336-2021

April 16, 2021

Class II

Product summary

Firm
Noven Pharmaceuticals Inc
Event
Event 87741
Status
Terminated
Classification
Class II
Quantity
12060 cartons
Official record key
drug-enforcement:D-0336-2021

Official wording

Reason: Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

Code information: Lot #: 88584 Exp. 03/2022

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out of specification